Your browser doesn't support javascript.
loading
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experience.
Bsat, Raghid; Chemaitelly, Hiam; Coyle, Peter; Tang, Patrick; Hasan, Mohammad R; Al Kanaani, Zaina; Al Kuwari, Einas; Butt, Adeel A; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad; Nasrallah, Gheyath K; Benslimane, Fatiha M; Al Khatib, Hebah A; Yassine, Hadi M; Al Kuwari, Mohamed G; Al Romaihi, Hamad Eid; Al-Thani, Mohamed H; Al Khal, Abdullatif; Bertollini, Roberto; Abu-Raddad, Laith J; Ayoub, Houssein H.
Afiliação
  • Bsat R; Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar.
  • Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Coyle P; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
  • Tang P; Hamad Medical Corporation, Doha, Qatar.
  • Hasan MR; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Al Kanaani Z; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom.
  • Al Kuwari E; Department of Pathology, Sidra Medicine, Doha, Qatar.
  • Butt AA; Department of Pathology, Sidra Medicine, Doha, Qatar.
  • Jeremijenko A; Hamad Medical Corporation, Doha, Qatar.
  • Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar.
  • Latif AN; Hamad Medical Corporation, Doha, Qatar.
  • Shaik RM; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.
  • Nasrallah GK; Hamad Medical Corporation, Doha, Qatar.
  • Benslimane FM; Hamad Medical Corporation, Doha, Qatar.
  • Al Khatib HA; Hamad Medical Corporation, Doha, Qatar.
  • Yassine HM; Hamad Medical Corporation, Doha, Qatar.
  • Al Kuwari MG; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Al Romaihi HE; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Al-Thani MH; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Al Khal A; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Bertollini R; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Abu-Raddad LJ; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Ayoub HH; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
J Glob Health ; 12: 05004, 2022.
Article em En | MEDLINE | ID: mdl-35136602
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Glob Health Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Glob Health Ano de publicação: 2022 Tipo de documento: Article